Perkenalan

Halaman ini memberikan analisis komprehensif tentang riwayat insider trading yang diketahui di Reshma Kewalramani. Insider adalah pejabat, direktur, atau investor penting dalam suatu perusahaan. Adalah ilegal bagi insider untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik dan non-publik. Hal ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan ke SEC melalui Formulir 4. Meskipun ada pembatasan ini, penelitian akademis menunjukkan bahwa insider – secara umum – cenderung mengungguli pasar di perusahaan mereka sendiri.

Profitabilitas Perdagangan Rata-rata

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari seluruh pembelian pasar terbuka yang dilakukan oleh insider dalam 3 tahun terakhir. Untuk menghitungnya, kami memeriksa setiap pembelian pasar terbuka dan tidak terencana yang dilakukan oleh insider, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata perdagangan tersebut selama 3, 6, dan 12 bulan, merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami menghitung rata-rata semua metrik kinerja untuk menghitung metrik kinerja bagi insider. Daftar ini hanya mencakup insider yang telah melakukan setidaknya tiga perdagangan dalam 2 tahun terakhir.

Jika profitabilitas perdagangan insider ini adalah "T/A", maka insider tersebut belum melakukan pembelian di pasar terbuka dalam 3 tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang dapat diandalkan.

Frekuensi Pembaruan: Harian

Lihat daftar insider trader yang paling menguntungkan.

Perusahaan dengan Posisi Insider yang Dilaporkan

Pengajuan SEC menunjukkan Reshma Kewalramani telah melaporkan kepemilikan atau perdagangan di perusahaan berikut:

Keamanan Judul Kepemilikan Terbaru yang Dilaporkan
US:VRTX / Vertex Pharmaceuticals Incorporated CEO & President, Director 98.278
Director 186.002
Bagaimana Menafsirkan Grafik

Bagan berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka dan tidak terencana yang dilakukan oleh Reshma Kewalramani. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham dipetakan sebagai persentase perubahan kumulatif harga saham. Misalnya, jika perdagangan insider dilakukan pada tanggal 1 Januari 2019, grafik akan menunjukkan persentase perubahan harian sekuritas hingga hari ini. Jika harga saham naik dari $10 menjadi $15 selama waktu ini, persentase perubahan harga saham kumulatif akan menjadi 50%. Perubahan harga dari $10 menjadi $20 adalah 100%, dan perubahan harga dari $10 menjadi $5 adalah -50%.

Pada akhirnya, kami mencoba untuk menentukan seberapa dekat korelasi perdagangan insider dengan keuntungan berlebih (positif atau negatif) pada harga saham untuk melihat apakah insider mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi insider. Pertimbangkan situasi di mana insider melakukan hal ini. Dalam situasi ini, kita mengharapkan (a) keuntungan positif setelah pembelian, atau (b) keuntungan negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, yang menunjukkan keuntungan positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, yang menunjukkan keuntungan negatif setelah setiap transaksi penjualan.

Namun, hal ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam kenaikan non-siklus selama bertahun-tahun, maka kita perkirakan semua lahan pasca pembelian akan miring ke atas. Demikian pula, penurunan non-siklus selama bertahun-tahun akan mengakibatkan penurunan pasca-perdagangan. Tak satu pun dari grafik ini menunjukkan aktivitas insider trading.

Indikator terkuat adalah situasi di mana harga saham sangat bersiklus, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat memberi isyarat kepada insider yang mengatur waktu perdagangan demi keuntungan finansial mereka.

Riwayat Insider Trading

Tabel ini menunjukkan daftar lengkap perdagangan insider yang dilakukan oleh Reshma Kewalramani sebagaimana diungkapkan kepada Securities Exchange Commission (SEC).

Tanggal Berkas Tanggal Trans Formulir Kode Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Mengubah
Saham
Harga
Trans
Nilai
Tersisa
Nilai
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.725 98.278 -1,72 496,95 -857.239 48.839.252
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.995 100.003 -5,66 496,16 -2.974.479 49.617.488
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.580 105.998 -12,81 495,38 -7.718.020 52.509.289
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.498 121.578 -2,80 494,33 -1.729.166 60.099.653
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.520 125.076 -1,97 493,29 -1.243.091 61.698.740
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -949 127.596 -0,74 491,30 -466.244 62.687.915
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.725 128.545 -2,08 490,54 -1.336.722 63.056.464
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -460 131.270 -0,35 489,32 -225.087 64.233.036
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.278 131.730 -2,43 488,27 -1.600.549 64.319.807
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.510 135.008 -1,83 487,13 -1.222.696 65.766.447
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -240 137.518 -0,17 482,84 -115.882 66.399.191
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -120 137.758 -0,09 481,50 -57.780 66.330.477
2026-03-03 2026-02-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 137.878 -0,29 479,75 -191.900 66.146.970
2026-02-26 2026-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -4.981 138.278 -3,48 485,11 -2.416.333 67.080.041
2026-02-19 2026-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -6.554 143.259 -4,37 483,75 -3.170.498 69.301.541
2026-02-19 2026-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 16.326 149.813 12,23
2026-02-18 2026-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -13.041 133.487 -8,90 487,76 -6.360.878 65.109.619
2026-02-12 2026-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.297 146.528 -5,36 468,41 -3.886.398 68.635.180
2026-01-26 2026-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 11.885 154.825 8,31
2026-01-26 2026-01-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26.972 142.940 23,26
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 5.710 115.968 5,18 389,95 2.226.614 45.221.722
2025-08-07 2025-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4.290 110.258 4,05 389,08 1.669.153 42.899.183
2025-02-28 2025-02-26 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -14.079 105.915 -11,73 479,61 -6.752.429 50.797.893
2025-02-26 2025-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.386 119.994 -7,25 483,28 -4.536.066 57.990.700
2025-02-19 2025-02-14 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -6.553 129.380 -4,82 463,46 -3.037.053 59.962.455
2025-02-14 2025-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 19.015 135.933 16,26
2025-02-12 2025-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.300 116.918 -6,63 467,98 -3.884.234 54.715.286
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20.328 125.218 19,38
2025-02-06 2025-02-04 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.118 104.890 38,43
2024-11-12 2024-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.198 75.772 -16,71 515,00 -7.826.970 39.022.580
2024-08-01 2024-07-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.202 90.970 -14,32 505,00 -7.677.010 45.939.850
2024-07-24 2024-07-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.202 106.172 -12,52 497,00 -7.555.394 52.767.484
2024-06-14 2024-06-12 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 105.263 186.002 130,37
2024-05-29 2024-05-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.565 121.374 -1,27 457,00 -715.205 55.467.918
2024-05-29 2024-05-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.565 122.939 1,29 187,53 293.484 23.054.751
2024-05-22 2024-05-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -15.202 121.374 -11,13 447,00 -6.795.294 54.254.178
2024-02-27 2024-02-23 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.386 136.507 -6,43 431,79 -4.052.781 58.942.358
2024-02-21 2024-02-20 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -7.019 145.893 -4,59 420,58 -2.952.051 61.359.678
2024-02-21 2024-02-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.359 152.912 -5,77 424,01 -3.968.310 64.836.217
2024-02-13 2024-02-09 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.255 162.271 -4,84 422,74 -3.489.719 68.598.443
2024-02-08 2024-02-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 20.327 170.526 13,53
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26.972 150.199 21,89
2024-02-08 2024-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 14.516 123.227 13,35
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -17.135 108.711 -13,62 407,00 -6.973.945 44.245.377
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 14.077 125.846 12,59 187,53 2.639.860 23.599.900
2023-12-19 2023-12-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.058 111.769 2,81 155,57 475.733 17.387.903
2023-12-15 2023-12-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.098 108.711 -4,48 397,00 -2.023.906 43.158.267
2023-11-15 2023-11-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.097 113.809 -4,29 377,00 -1.921.569 42.905.993
2023-07-18 2023-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7.828 118.906 -6,18 355,00 -2.778.940 42.211.630
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -38 126.652 -0,03 340,19 -12.927 43.085.744
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.668 126.690 -1,30 339,43 -566.169 43.002.387
2023-05-01 2023-04-27 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.611 128.358 -1,24 338,69 -545.630 43.473.571
2023-02-28 2023-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.386 129.969 -6,74 289,12 -2.713.680 37.576.637
2023-02-22 2023-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -9.359 139.355 -6,29 292,85 -2.740.783 40.810.112
2023-02-14 2023-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -5.990 148.714 -3,87 298,26 -1.786.577 44.355.438
2023-02-14 2023-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.372 154.704 -2,13 294,33 -992.481 45.534.028
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 26.972 158.076 20,57
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.118 131.104 28,55
2023-02-03 2023-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.388 101.986 13,83
2023-01-27 2023-01-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.000 89.598 -10,04 315,05 -3.150.500 28.227.850
2022-11-10 2022-09-30 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 9.818 80.739 13,84
2022-08-17 2022-08-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11.689 99.598 -10,50 305,06 -3.565.846 30.383.366
2022-06-28 2022-06-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -11.689 111.153 -9,52 291,30 -3.405.006 32.378.869
2022-06-13 2022-06-10 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
A - Award 70.921 70.921
2022-02-28 2022-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -7.246 122.842 -5,57 227,86 -1.651.074 27.990.778
2022-02-22 2022-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -8.584 130.088 -6,19 232,51 -1.995.866 30.246.761
2022-02-14 2022-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -3.031 138.672 -2,14 237,74 -720.590 32.967.881
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.117 141.703 25,86
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.032 112.586 34,75
2022-02-03 2022-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9.800 83.554 13,29
2021-11-23 2021-11-19 4 DNA Ginkgo Bioworks Holdings, Inc.
Restricted Stock Units
A - Award 9.818 9.818
2021-09-20 2021-09-16 4 DNA Ginkgo Bioworks Holdings, Inc.
Stock Option
A - Award 17.649 17.649
2021-09-20 2021-09-16 4 DNA Ginkgo Bioworks Holdings, Inc.
Stock Option
A - Award 51.782 51.782
2021-08-23 2021-08-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 4.243 73.754 6,10 196,34 833.071 14.480.860
2021-08-23 2021-08-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
P - Purchase 5.757 69.511 9,03 195,14 1.123.421 13.564.377
2021-02-26 2021-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.898 63.643 -4,36 217,57 -630.518 13.846.808
2021-02-19 2021-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.080 66.541 -3,03 211,75 -440.440 14.090.057
2021-02-12 2021-02-10 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.962 68.621 -4,14 214,16 -634.342 14.695.873
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 29.031 71.583 68,22
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.388 42.552 41,07
2021-02-05 2021-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3.516 30.164 13,19
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -509 3.058 -14,27
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.564 15.642 -9,09
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -93 26.626 -0,35 273,27 -25.414 7.276.087
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -487 26.719 -1,79 272,76 -132.834 7.287.874
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -471 27.206 -1,70 271,42 -127.839 7.384.253
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -870 27.677 -3,05 270,36 -235.213 7.482.754
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -152 28.547 -0,53 269,11 -40.905 7.682.283
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 509 28.699 1,81 155,57 79.185 4.464.703
2020-08-10 2020-08-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.564 28.190 5,87 187,53 293.297 5.286.471
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9 26.626 -0,03 288,37 -2.595 7.678.140
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -19 26.635 -0,07 287,63 -5.465 7.661.025
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -27 26.654 -0,10 286,07 -7.724 7.624.910
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10 26.681 -0,04 283,76 -2.838 7.571.001
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4 26.691 -0,01 282,74 -1.131 7.546.613
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6 26.695 -0,02 281,74 -1.690 7.521.049
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -9 26.701 -0,03 280,47 -2.524 7.488.829
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -7 26.710 -0,03 279,70 -1.958 7.470.787
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -6 26.717 -0,02 276,40 -1.658 7.384.579
2020-05-19 2020-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2 26.723 -0,01 274,37 -549 7.331.990
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -510 3.567 -12,51
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.564 17.206 -8,33
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -134 26.626 -0,50 275,17 -36.873 7.326.676
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -864 26.760 -3,13 274,04 -236.771 7.333.310
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -360 27.624 -1,29 272,77 -98.197 7.534.998
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 27.984 -1,06 271,92 -81.576 7.609.409
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -416 28.284 -1,45 270,35 -112.466 7.646.579
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 510 28.700 1,81 155,57 79.341 4.464.859
2020-05-08 2020-05-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.564 28.190 5,87 187,53 293.297 5.286.471
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -111 26.626 -0,42 239,13 -26.543 6.367.075
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -420 26.737 -1,55 238,28 -100.078 6.370.892
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -320 27.157 -1,16 236,71 -75.747 6.428.333
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -340 27.477 -1,22 235,36 -80.022 6.466.987
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -660 27.817 -2,32 234,41 -154.711 6.520.583
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -440 28.477 -1,52 232,35 -102.234 6.616.631
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -450 28.917 -1,53 230,88 -103.896 6.676.357
2020-02-26 2020-02-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -893 29.367 -2,95 229,72 -205.140 6.746.187
2020-02-26 2020-02-24 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -2.898 30.260 -8,74 239,23 -693.289 7.239.100
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -129 33.158 -0,39 245,75 -31.702 8.148.578
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -260 33.287 -0,78 244,94 -63.684 8.153.318
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -134 33.547 -0,40 243,76 -32.664 8.177.417
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -540 33.681 -1,58 242,62 -131.015 8.171.684
2020-02-19 2020-02-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -120 34.221 -0,35 241,71 -29.005 8.271.558
2020-02-19 2020-02-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
F - Taxes -944 34.341 -2,68 241,50 -227.976 8.293.352
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -510 4.077 -11,12
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.564 18.770 -7,69
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -129 35.285 -0,36 242,47 -31.279 8.555.554
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -271 35.414 -0,76 240,75 -65.243 8.525.920
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -423 35.685 -1,17 239,69 -101.389 8.553.338
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.251 36.108 -3,35 238,76 -298.689 8.621.146
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise -510 37.359 -1,35 155,57 -79.341 5.811.940
2020-02-07 2020-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise -1.564 36.849 -4,07 187,53 -293.297 6.910.293
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.387 35.285 54,10
2020-02-07 2020-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9.800 22.898 74,82
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy)
M - Exercise -4.692 20.334 -18,75
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.692 13.098 -26,37 219,37 -1.029.284 2.873.308
2019-11-26 2019-11-25 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 4.692 17.790 35,82 187,53 879.891 3.336.159
2019-11-19 2019-11-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -61 13.098 -0,46 205,95 -12.563 2.697.533
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -509 4.587 -9,99
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -509 13.098 -3,74 199,00 -101.291 2.606.502
2019-11-13 2019-11-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 509 13.607 3,89 155,57 79.185 2.116.841
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -3.057 5.096 -37,50
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.057 13.098 -18,92 199,00 -608.343 2.606.502
2019-10-31 2019-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.057 16.155 23,34 155,57 475.577 2.513.233
2019-10-24 2019-10-22 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -638 13.098 -4,64 189,00 -120.582 2.475.522
2019-05-17 2019-05-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -241 13.736 -1,72 165,41 -39.864 2.272.072
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 13.736 -0,72 188,49 -18.849 2.589.099
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -202 13.836 -1,44 187,27 -37.829 2.591.068
2019-02-21 2019-02-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.186 14.038 -7,79 186,75 -221.486 2.621.596
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 25.026 25.026
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 9.799 15.224 180,63
2019-02-08 2019-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 3.516 5.425 184,18
2018-10-09 2018-10-08 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.305 1.909 -54,70 186,95 -430.920 356.888
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.428
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.428
2018-04-02 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
8.428
2018-04-02 3/A VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
4.214
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)